Biohope, “Biotech of the Week”
Biohope has been chosen "Biotech of the Week" by Labiotech.eu, the leading digital media covering of the European Biotech industry. " This technique could help to reduce the number of patients experiencing kidney transplant rejection, which [...]
BH-Pilot results will be presented in this October
Biohope will present a poster in the framework of the BST (Basic Science in Transplantation) congress that takes place from October 11th to 13th in Rotterdam. It shows the biotechnological principles of the Immunobiogram (IMBG) [...]
Biohope in Biospain 2018
Biohope participates in BIOSPAIN 2108, the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.000) and companies participating [...]
Biohope, finalist in IV edition of the “RTVE Emprende Awards”
RTVE (National Spanish Television Channel) organized the IV Edition of the 'RTVE Emprende Awards', whose objective is to inform about companies that have stood out for their excellence in the professional field, contributing inherent values to the entrepreneur such [...]
Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE
"Closer to the personalization of renal transplant treatment. First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response." > Read More
Interview with Isabel Portero, Founder and Director of Biohope
Isabel talks about the way she has professionally evolved, the achievements she has made and the promising future of Biohope, a highly qualified innovative Clinical stage biotech Company, thanks to the enthusiasm, ability to work [...]